Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03045822
PHASE4

BIA and Cardiac Implantable Electronic Devices

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

There are an increase number of patients with cardiac implantable electronic devices (CIEDs) such as pacemakers (PM) and implantable cardioverter-defibrillators (ICDs) worldwide. The current medical practice guidelines warn on performing bioimpedance analysis (BIA) in this group of patients to avoid any electromagnetic interference. These recommendations restrict the use of BIA in many patients with heart failure in whom BIA might be of great interest in detecting peripheral congestion and in guidance of treatment. However, it is not well known whether BIA can affect the function of cardiac devices. Investigators aimed to test the incidence of electromagnetic interference between BIA and CIEDs.

Official title: Evaluation of the Impact of Bioimpedance Analysis in Patients With Cardiac Implantable Electronic Devices

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2014-03-18

Completion Date

2017-01-16

Last Updated

2026-08-05

Healthy Volunteers

No

Interventions

DRUG

Bioimpedance analysis

Locations (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France